EOF recalls batch of leukemia medication due to non-compliance

1 sourceFirst reported 1 month agoUpdated 1 month ago

AI summary: catch up in 20 seconds

EOF announced the recall of a batch of leukemia medication due to off-spec findings.
The specific batch being recalled is H0444C with an expiration date of 07/2027.
The recall affects the drug NILOTINIB TEVA caps 200mg/cap BT x 112.
TEVA HELLAS is required to contact recipients and withdraw the batch promptly.
The medication is used for the treatment of adult and pediatric patients with CML.

Generated by AI from the 1 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 1 sources below · always verify with the originals

All coverage (1)

No comments yet. Be the first to join the discussion.

AI summary: catch up in 20 seconds

EOF announced the recall of a batch of leukemia medication due to off-spec findings.
The specific batch being recalled is H0444C with an expiration date of 07/2027.
The recall affects the drug NILOTINIB TEVA caps 200mg/cap BT x 112.
TEVA HELLAS is required to contact recipients and withdraw the batch promptly.
The medication is used for the treatment of adult and pediatric patients with CML.

Generated by AI from the 1 sources below · always verify with the originals